SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-121745"
 

Search: onr:"swepub:oai:DiVA.org:liu-121745" > Association between...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Edner, MagnusKarolinska Institutet (author)

Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • 2015-06-11
  • OXFORD UNIV PRESS,2015
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-121745
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-121745URI
  • https://doi.org/10.1093/eurheartj/ehv268DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:131958966URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation; Swedish Research Council from the Swedish Heart-Lung Foundation [2013-23897-104604-23, 20080409, 20100419]; Stockholm County Council [00556-2009, 20110120]
  • Aims In heart failure (HF) with reduced ejection fraction (EF), renin-angiotensin receptor (RAS) antagonists reduce mortality. However, severe renal insufficiency was an exclusion criterion in trials. We tested the hypothesis that RAS antagonists are associated with reduced mortality also in HF with severe renal insufficiency. Methods and results We studied patients with EF less than= 39% registered in the prospective Swedish Heart Failure Registry. In patients with creatinine greater than221 mu mol/L or creatinine clearance less than30 mL/min, propensity scores for RAS-antagonist use were derived from 36 variables. The association between RAS antagonist use and all-cause mortality was assessed with Cox regression in a cohort matched 1:1 based on age and propensity score. To assess consistency, we performed the same analysis as a positive control in patients without severe renal insufficiency. Between 2000 and 2013, there were 24 283 patients of which 2410 [age, mean (SD), 82 (9), 45% women] had creatinine greater than221 mu mol/L or creatinine clearance less than30 mL/min and were treated (n = 1602) or not treated (n = 808) with RAS antagonists. In the matched cohort of 602 vs. 602 patients [age 83 (8), 42% women], RAS antagonist use was associated with 55% [95% confidence interval (CI) 51-59] vs. 45% (41-49) 1-year survival, P less than 0.001, with a hazard ratio (HR) for mortality of 0.76 (95% CI 0.67-0.86, P less than 0.001). In positive control patients without severe renal insufficiency [n = 21 873; age 71 (12), 27% women], the matched HR was 0.79 (95% CI 0.72-0.86, P less than 0.001). Conclusion In HF with severe renal insufficiency, the use of RAS antagonists was associated with lower all-cause mortality. Prospective randomized trials are needed before these findings can be applied to clinical practice.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Benson, LinaKarolinska Institutet (author)
  • Dahlström, UlfLinköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)ulfda85 (author)
  • Lund, Lars H.Karolinska Institutet (author)
  • Karolinska InstitutetAvdelningen för kardiovaskulär medicin (creator_code:org_t)

Related titles

  • In:European Heart Journal: OXFORD UNIV PRESS36:34, s. 2318-23260195-668X1522-9645

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Edner, Magnus
Benson, Lina
Dahlström, Ulf
Lund, Lars H.
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
Articles in the publication
European Heart J ...
By the university
Linköping University
Karolinska Institutet

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view